Journal of Psychiatric Research
June 6, 2026
Kemeng Zhu, Maoxin Hu, Chaomeng Liu et al.
Background: Late-life depression (LLD) is a growing public health concern in aging populations. Although digital mindfulness interventions show promise for depression, anxiety, and insomnia, their efficacy and electroencephalogram (EEG) correlates in older adults with LLD remain unclear. This study evaluated the FocusZen Mindfulness Stress Reduction System, a digital mindfulness intervention...
Frontiers in Pharmacology
September 17, 2025
Xiao Wang, Lijuan Yan, Jiaying Cai et al.
1 citation
This trial aims to provide Level I evidence comparing the respiratory depression risk between esketamine-based and fentanyl-based analgesia during HHNB-guided liver ablation. Should esketamine prove to be demonstrably superior in terms of respiratory safety, HHNB-esketamine has the potential to be a viable treatment option.
Mindfulness
June 1, 2020
Kristina Sundquist, Karolina Palmér, Ashfaque A. Memon et al.
Abstract Objectives Identification of biological markers that can guide treatment selection is considered to be a viable solution for personalized treatment for patients with psychiatric disorders. This study investigated whether macrophage migration inhibitory factor (MIF) levels at baseline were associated with mindfulness-based group therapy or cognitive behavioral therapy response in...
Early Intervention in Psychiatry
July 3, 2018
Jan Sundquist, Karolina Palmér, Ashfaque A. Memon et al.
Although mindfulness‐based group therapies (MGTs) for depressive, anxiety or stress and adjustment disorders are promising, there is a substantial lack of knowledge regarding the long‐term improvements after such therapies in these common psychiatric disorders.
The International Journal of Neuropsychopharmacology
January 10, 2018
Xiao Wang, Kristina Sundquist, Karolina Palmér et al.
26 citations
Background: Macrophage migration inhibitory factor is a proinflammatory cytokine that has been associated with various psychiatric disorders. MicroRNA-451a can directly target macrophage migration inhibitory factor and downregulate its expression in cells. However, the role of macrophage migration inhibitory factor and microRNA-451a in psychiatric patients treated with psychotherapeutic...